| 1 |
NNOX
|
ai
cloud
healthcare
medical devices
software
|
NANO-X IMAGING LTD
|
8.2x
|
0.35
|
Nanox is a distressed real option on turning FDA-cleared low-cost 3D imaging hardware into a managed imaging utility with cloud, AI, remote reads, and healthcare IT attached; if financing and activations clear, each live site can become a recurring revenue node and the equity can rerate far faster than today’s scale implies.
|
| 2 |
HURA
|
biotech
healthcare
|
TuHURA Biosciences, Inc.
|
5.6x
|
0.25
|
TuHURA is a survival-to-scale rare-oncology bet: if IFx-2.0 reaches approval on time and management uses partnering to reduce dilution, the company can move from distressed optionality to a small but credible orphan-oncology revenue story by 2031, with TBS-2025 and DOR assets adding upside rather than carrying the case.
|
| 3 |
DNA
|
ai
automation
biotech
healthcare
|
Ginkgo Bioworks Holdings, Inc.
|
4.7x
|
0.40
|
Ginkgo is a real-asset option on biology becoming more like cloud infrastructure: if Nebula, Cloud Lab, and customer-site deployments convert into repeat paid throughput before financing pressure bites, revenue can compound sharply and the stock can rerate from shrinking services vendor toward niche research infrastructure.
|
| 4 |
NTLA
|
ai
biotech
healthcare
|
Intellia Therapeutics, Inc.
|
4.6x
|
0.45
|
The 5-year upside is a category shift: if lonvo-z clears FDA and gains payer-backed adoption, Intellia can move from a cash-burning CRISPR platform to a rare-disease franchise with reusable reimbursement, treatment-center and clinical-data infrastructure, while nex-z and selective licensing add a second leg of value.
|
| 5 |
AISP
|
ai
defense
enterprise
hardware
software
|
Airship AI Holdings, Inc.
|
4.3x
|
0.40
|
Airship can outgrow a typical micro-cap contractor if it converts a real federal pipeline into repeat deployments and then captures recurring value in evidence, support, and partner distribution; in the AI era, its edge is trusted workflow embedding, not model ownership.
|
| 6 |
ACHR
|
aerospace
automation
defense
evtol
transportation
|
Archer Aviation Inc.
|
4.3x
|
0.52
|
Archer can grow into a regulated launch-and-operations platform, not just an aircraft maker, if 2026 certification progress turns into repeatable city deployments and the company captures recurring economics in training, dispatch, maintenance, and selected node access.
|
| 7 |
RXRX
|
ai
automation
biotech
healthcare
software
|
Recursion Pharmaceuticals, Inc.
|
4.3x
|
0.60
|
Recursion can benefit from the AI era because its scarce asset is not generic software but a closed loop of proprietary data, automated experiments, and owned drug programs; if the lead rare-disease asset earns a clear late-stage path and partner economics shift toward milestones and royalties, the stock can rerate from concept status to a higher-quality product-plus-platform biotech by 2031.
|
| 8 |
RR
|
ai
automation
enterprise
hardware
robotics
|
Richtech Robotics Inc.
|
3.9x
|
0.45
|
Richtech is a cash-backed option on service robotics adoption: if it turns early hospitality and industrial deployments into dense recurring contracts and partner-led distribution, revenue can scale non-linearly from a tiny base; if not, it remains a richly valued robot integrator with weak bargaining power.
|
| 9 |
PRME
|
biotech
healthcare
|
Prime Medicine, Inc.
|
3.6x
|
0.35
|
Prime Medicine is a financing-constrained but asymmetric option on prime-editing validation: if PM577 and PM647 enter the clinic on time and 2027 liver data confirm reusable biology, the story can rerate from platform optionality to a multi-asset liver franchise with licensing leverage by 2031.
|
| 10 |
SERV
|
ai
automation
healthcare
robotics
transportation
|
Serve Robotics Inc.
|
3.6x
|
0.60
|
Serve can create meaningful value if it turns robot count into revenue density: higher revenue per robot, more recurring software and hospital workflows, and a trust/compliance layer that lets it capture value beyond basic autonomy while city permissioning and platform dependence remain the main caps on upside.
|
| 11 |
APUS
|
ai
biotech
crypto
finance
healthcare
|
Apimeds Pharmaceuticals US, Inc.
|
3.6x
|
0.20
|
APUS is a distressed option on clearing near-term capital gates, separating a messy hybrid structure, and turning retained Apitox economics plus trust-heavy treasury workflows into a financeable niche business by 2031.
|
| 12 |
SDGR
|
ai
biotech
enterprise
healthcare
software
|
Schrödinger, Inc.
|
3.6x
|
0.60
|
If Schrödinger converts its installed pharma footprint into a deeper hosted workflow layer, it can grow from a respected modeling vendor into a higher-quality discovery operating system with partner-funded drug upside; the real bet is on more throughput, trust, and budget share per large account, not on self-funding a big pipeline.
|
| 13 |
BEAM
|
biotech
healthcare
|
Beam Therapeutics Inc.
|
3.5x
|
0.35
|
Beam can rerate from cash-backed platform optionality to a two-franchise genetic-medicine company by 2031 if risto-cel reaches market on the stated path and BEAM-302 converts early in vivo proof into a registrational liver franchise, with additional upside from platform reuse, partner economics, and tighter control of manufacturing and treatment workflows.
|
| 14 |
QUBT
|
ai
communications
hardware
quantum
semiconductors
|
Quantum Computing Inc.
|
3.3x
|
0.44
|
QCi’s best 5-year path is not winning general-purpose quantum computing; it is becoming a scarce U.S. photonics process, packaging, and secure-communications supplier with attached edge-AI and optimization products. If Fab 1 converts backlog into repeat orders and Fab 2 is financed against demand, value creation can still land in the 2-5x zone despite a rich starting valuation.
|
| 15 |
AI
|
ai
cloud
defense
enterprise
software
|
C3.ai, Inc.
|
3.3x
|
0.40
|
C3 AI is a cash-backed enterprise AI turnaround: if it converts pilots into repeatable production contracts, adds higher-value trust and compliance layers, and scales through partners, revenue can plausibly reach 1000 by 2031 and support a little over 2x equity upside without needing frontier-model leadership.
|
| 16 |
MSTR
|
ai
crypto
enterprise
finance
software
|
Strategy Inc
|
3.0x
|
0.40
|
Over the next five years, Strategy can still compound materially if it preserves market access, adds bitcoin per common share faster than senior claims grow, and turns its software from seat-based BI into a higher-trust verification layer for finance and agent workflows.
|
| 17 |
PDYN
|
aerospace
ai
defense
robotics
software
|
Palladyne AI Corp.
|
3.0x
|
0.60
|
Palladyne can grow from a tiny base into a meaningful defense-autonomy supplier if it converts demos and backlog into repeat procurement, then shifts mix toward software, assurance, and partner royalties; the upside is real, but equity value depends on proving procurement pull before dilution and prime insourcing weaken the moat.
|
| 18 |
MBLY
|
ai
automation
automotive
semiconductors
software
|
Mobileye Global Inc.
|
3.0x
|
0.66
|
Mobileye should compound from a cash-generative ADAS chip base into a higher-value automotive trust layer as content per vehicle rises, but the equity outcome depends on converting 2027-era advanced launches into shipped programs before OEMs compress its economics back to premium-component levels.
|
| 19 |
INOD
|
ai
enterprise
software
|
Innodata Inc.
|
2.9x
|
0.45
|
Innodata can compound well if it turns hyperscaler-led AI data work into recurring assurance and governed workflow revenue; the opportunity is real because AI deployment is exploding, but the five-year winner is the vendor that becomes embedded in release-to-run control loops rather than staying a premium contractor.
|
| 20 |
RDVT
|
ai
cloud
enterprise
finance
software
|
Red Violet, Inc.
|
2.7x
|
0.60
|
RDVT is a profitable identity-intelligence utility that can roughly triple revenue by 2031 if it climbs from lookup vendor to embedded trust layer across fraud, onboarding, monitoring, and real-estate safety workflows; the main ceiling is data-rights durability, not demand.
|
| 21 |
CRSP
|
ai
biotech
healthcare
|
CRISPR Therapeutics AG
|
2.7x
|
0.50
|
CRISPR Therapeutics has already cleared the basic science credibility hurdle with CASGEVY; the five-year equity upside now depends on turning that proof into at least one additional owned franchise with real commercial economics, most plausibly in autoimmune cell therapy or liver-directed cardiometabolic editing.
|
| 22 |
RCAT
|
aerospace
automation
defense
hardware
robotics
|
Red Cat Holdings, Inc.
|
2.7x
|
0.60
|
Red Cat can grow from a lumpy drone seller into a broader Western small-systems defense supplier if Black Widow validation, allied procurement, maritime expansion, and recurring readiness-style support convert compliance advantage into repeat revenue and better margins before hardware economics commoditize.
|
| 23 |
ESTC
|
ai
cloud
cybersecurity
enterprise
software
|
Elastic N.V.
|
2.7x
|
0.60
|
Elastic is a discounted AI-era data and trust layer: if it keeps converting search, observability, and security workloads into larger cloud commitments, regulated deployments, and agent-facing governance spend, revenue can roughly double by 2031 while the valuation rerates modestly from a challenged-tool discount toward infrastructure software levels.
|
| 24 |
AUR
|
ai
automation
automotive
robotics
transportation
|
Aurora Innovation, Inc.
|
2.7x
|
0.63
|
Aurora has a credible shot to turn highway autonomy from a science project into a contracted freight-capacity layer, but the equity only compounds well if safety proof, OEM integration, and route density convert into thousands of trucks and recurring corridor economics before dilution and partner bargaining absorb the value.
|
| 25 |
RLAY
|
ai
biotech
healthcare
|
Relay Therapeutics, Inc.
|
2.7x
|
0.35
|
Relay is a leveraged but credible bet that zovegalisib becomes a multi-indication PI3Kα franchise while its discovery engine improves follow-on hit rates; if late-stage proof holds, the story can rerate from single-asset biotech to emerging precision-medicine franchise by 2031.
|
| 26 |
S
|
ai
cloud
cybersecurity
enterprise
software
|
SentinelOne, Inc.
|
2.7x
|
0.58
|
SentinelOne can roughly 2.4x equity value by 2031 if it keeps turning endpoint landings into broader cloud, data, identity, and AI-security contracts, using workflow integration, partner routes, and regulated deployment options to monetize trusted automation faster than larger suites compress pricing.
|
| 27 |
QBTS
|
cloud
enterprise
hardware
quantum
software
|
D-Wave Quantum Inc.
|
2.6x
|
0.60
|
D-Wave can become a recurring optimization-compute platform rather than a seller of one-off quantum experiments, but because the stock already discounts major success, the next five years depend on converting today’s bookings, RPO, and dual-platform roadmap into installed systems, renewing cloud usage, and embedded workflow revenue fast enough to outrun multiple compression.
|
| 28 |
LMND
|
ai
finance
software
|
Lemonade, Inc.
|
2.6x
|
0.46
|
Lemonade can become a materially larger personal-lines insurer by 2031 if AI-led underwriting, telematics, household bundling, and embedded distribution keep improving loss costs and acquisition efficiency faster than reinsurance and regulatory capital needs rise.
|
| 29 |
IREN
|
ai
cloud
crypto
energy
hardware
|
IREN Limited
|
2.6x
|
0.76
|
IREN can still create strong 5-year equity upside by turning scarce power-backed campuses into contracted AI infrastructure faster than capex, depreciation and dilution erode per-share value; the nonlinear upside comes if it evolves from a mining transition story into a repeatable allocator, builder and operator of powered compute.
|
| 30 |
JOBY
|
aerospace
automation
defense
evtol
transportation
|
Joby Aviation, Inc.
|
2.6x
|
0.60
|
Joby is best viewed as a regulated mobility platform with aircraft, operating authority, launch infrastructure, and partner distribution; if it converts its certification lead into dense premium corridors and recurring fleet-service revenue, the equity can still compound well even after the recent rerating.
|
| 31 |
TEM
|
ai
biotech
enterprise
healthcare
software
|
Tempus AI, Inc.
|
2.6x
|
0.60
|
Tempus can still compound into a much larger precision-medicine platform if it keeps turning each diagnostic interaction and provider integration into governed data, then monetizes that data through higher-margin applications and workflow rails faster than reimbursement and financing drag can cap the story.
|
| 32 |
POET
|
ai
hardware
networking
semiconductors
|
POET Technologies Inc.
|
2.6x
|
0.58
|
POET has a real shot at turning niche photonics IP into a scaled AI-optics supplier because AI clusters need denser, lower-power links and the company is now well funded; the non-linear upside comes if qualification converts into repeat production across engines, light sources and selected modules before larger incumbents absorb the value.
|
| 33 |
ZS
|
ai
cloud
cybersecurity
enterprise
software
|
Zscaler, Inc.
|
2.6x
|
0.60
|
Zscaler’s inline trust gate should become more valuable as AI expands traffic, machine identities, data egress, and sovereignty needs; if it keeps shifting value capture from mostly seats toward broader platform, usage, and agent-governance modules, revenue can more than double by 2031 and support a solid 2-3x equity outcome without needing a full old-style SaaS multiple comeback.
|
| 34 |
PATH
|
ai
automation
cloud
enterprise
software
|
UiPath, Inc.
|
2.5x
|
0.58
|
UiPath can compound from a reset RPA multiple into a higher-value enterprise control layer if it proves that orchestration, trust, testing, and document-centric AI become paid system-of-record functions as agentic automation moves from pilots to production.
|
| 35 |
SMR
|
automation
energy
hardware
nuclear
|
NuScale Power Corporation
|
2.5x
|
0.68
|
NuScale has a real regulatory control point in U.S. small modular nuclear, and if it converts that lead into one binding U.S. project plus continued Romania progress, revenue can jump non-linearly by 2031; the upside is meaningful, but shareholder capture is capped by dilution, partner economics, and site-specific licensing gates.
|
| 36 |
NOW
|
ai
automation
cloud
enterprise
software
|
ServiceNow, Inc.
|
2.5x
|
0.70
|
ServiceNow is one of the few application software companies that can benefit from cheaper cognition because it sits in the governed action layer of enterprise work; if it keeps shifting monetization from human seats to verified actions, AI governance, security, and outcome-linked automation, it can compound well above mature software peers through 2031.
|
| 37 |
BFLY
|
ai
healthcare
medical devices
semiconductors
software
|
Butterfly Network, Inc.
|
2.5x
|
0.58
|
The 5-year upside is not just more probe sales; it is proving that Butterfly’s regulated ultrasound-on-chip stack can expand into enterprise workflow, Embedded royalties, and distributed-care imaging, creating a higher-margin business that is still hardware-anchored but no longer valued like a single-product device vendor.
|
| 38 |
COIN
|
ai
crypto
enterprise
finance
software
|
Coinbase Global, Inc.
|
2.5x
|
0.60
|
Coinbase can grow from a cycle-heavy crypto broker into a regulated onchain financial utility if stablecoin economics, derivatives, custody, and developer rails scale faster than spot-fee volatility and keep the company in the money-flow layer even as AI agents abstract the front end.
|
| 39 |
OUST
|
ai
automation
automotive
hardware
robotics
|
Ouster, Inc.
|
2.5x
|
0.60
|
Ouster can outgrow the lidar peer set if REV8 and StereoLabs turn it from a sensor vendor into a qualified sensing-and-perception stack with recurring software and workflow capture, but the stock’s current premium means execution must keep outrunning hardware commoditization.
|
| 40 |
SPIR
|
communications
defense
software
space
|
Spire Global, Inc.
|
2.5x
|
0.60
|
Spire owns real orbital control points—satellites, data rights, RFGL capacity, and sovereign-friendly manufacturing—but its equity only compounds if 2026-2027 converts that asset base into recurring government and workflow-embedded commercial revenue fast enough to reach self-funding.
|
| 41 |
NBIS
|
ai
cloud
enterprise
hardware
software
|
Nebius Group N.V.
|
2.4x
|
0.78
|
Nebius is a leveraged bet on AI infrastructure scarcity: if it keeps converting contracted power and financing into live, sold-out capacity while layering inference and sovereign-region software on top, revenue can compound far faster than normal cloud markets, but current valuation means equity upside now depends on disciplined execution rather than narrative alone.
|
| 42 |
SOUN
|
ai
automation
automotive
enterprise
software
|
SoundHound AI, Inc.
|
2.4x
|
0.46
|
If OASYS, Amelia, and LivePerson are integrated into a trusted action layer rather than a cheaper voice layer, SoundHound can turn real distribution across cars, phones, kiosks, and messaging into strong 5-year growth; the equity win still depends on better value capture and limited dilution.
|
| 43 |
FLNC
|
automation
energy
enterprise
software
|
Fluence Energy, Inc.
|
2.4x
|
0.62
|
Fluence is a leveraged play on AI-era power scarcity: if it turns backlog, hyperscaler qualification, and installed-base software/service attach into a cleaner operating model, it can outgrow the storage market and earn a better multiple without owning battery-cell manufacturing.
|
| 44 |
KTOS
|
aerospace
defense
hardware
software
space
|
Kratos Defense & Security Solutions, Inc.
|
2.4x
|
0.63
|
Kratos is a leveraged bet that AI-era warfare shifts spend toward affordable autonomous mass, propulsion, and mission-ground software; if it converts backlog and new awards into repeat production, revenue can more than double by 2031, though multiple expansion should stay modest because procurement timing, capex, and fixed-price execution remain real constraints.
|
| 45 |
OKLO
|
ai
defense
energy
nuclear
|
Oklo Inc.
|
2.4x
|
0.60
|
Oklo is a leveraged bet on AI-era power scarcity: if it turns licensing, fuel access, and first-site development into one operating Idaho unit plus an early Ohio campus and adjacent fuel and isotope revenue, today’s pre-revenue scarcity premium can still compound meaningfully through 2031.
|
| 46 |
AVAV
|
aerospace
ai
defense
robotics
space
|
AeroVironment, Inc.
|
2.4x
|
0.62
|
AV can still more than double equity value by May 2031 if it turns backlog, Army program positions, and BlueHalo-broadened products into repeat production, allied replenishment, and higher-value integrated systems. The upside comes from scale, contract access, and trust/compliance gates, not from pretending it is a pure software stock.
|
| 47 |
IONQ
|
cloud
defense
hardware
networking
quantum
|
IonQ, Inc.
|
2.3x
|
0.60
|
IonQ can grow into a real quantum infrastructure leader over the next five years if it converts 256-qubit roadmap proof, government trust, and SkyWater-enabled manufacturing control into repeatable multi-product revenue; the opportunity is large, but upside now depends on scaling revenue faster than valuation compresses.
|
| 48 |
BBAI
|
ai
defense
enterprise
software
transportation
|
BigBear.ai Holdings, Inc.
|
2.3x
|
0.40
|
BigBear.ai can roughly double enterprise value by May 2031 if Ask Sage and adjacent trade-and-travel products shift the company from a lumpy federal services contractor into a repeatable, accredited secure-AI software vendor; the upside is in owning the trusted workflow layer, not in building frontier models.
|
| 49 |
SNOW
|
ai
cloud
enterprise
software
|
Snowflake Inc.
|
2.3x
|
0.66
|
Snowflake can outgrow software norms if it becomes the governed execution layer for enterprise data and agent workflows; its usage model lets AI add spend rather than replace seats, but hyperscaler dependence likely caps upside to premium compounding instead of a frontier-AI rerating.
|
| 50 |
APLD
|
ai
cloud
energy
hardware
|
Applied Digital Corporation
|
2.3x
|
0.70
|
Applied Digital can still roughly double by 2031 if it converts its power-secured, lease-backed AI campuses into operating cash flow faster than financing costs and dilution absorb the economics; the edge is scarce powered capacity, not software.
|
| 51 |
FIVN
|
ai
cloud
communications
enterprise
software
|
Five9, Inc.
|
2.3x
|
0.40
|
Five9 is a depressed-multiple CCaaS asset that can compound if it proves AI, fixed commitments, and workflow control raise customer spend faster than automation reduces human-seat demand.
|
| 52 |
APP
|
advertising
ai
enterprise
media
software
|
AppLovin Corporation
|
2.3x
|
0.60
|
AppLovin is a rare ad-tech business where AI directly improves the core product, so self-serve expansion, non-gaming performance budgets, and connected-TV and publisher workflow adjacencies can drive a much larger revenue base; the stock still works if those gains arrive faster than the multiple normalizes from today’s premium.
|
| 53 |
CORZ
|
ai
cloud
crypto
energy
|
Core Scientific, Inc.
|
2.2x
|
0.66
|
Core Scientific can still compound meaningfully if it proves its powered campuses are scarce AI infrastructure rather than legacy mining real estate: the key is converting contracted and controlled megawatts into diversified, billable colocation revenue faster than leverage, concentration, and self-build competition compress the rerating.
|
| 54 |
AMBA
|
ai
automotive
hardware
robotics
semiconductors
|
Ambarella, Inc.
|
2.2x
|
0.63
|
Ambarella can grow from a niche edge-AI chip vendor into a broader physical-AI compute supplier as higher-ASP automotive, security, robotics and semi-custom programs convert into production, with added upside if LTAs and ecosystem tooling make design wins more repeatable.
|
| 55 |
RIOT
|
ai
cloud
crypto
energy
hardware
|
Riot Platforms, Inc.
|
2.2x
|
0.52
|
Riot is a scarce-power and time-to-deploy bet, not a software bet; if it turns Rockdale and Corsicana into repeatable, financed AI campuses, the business can shift from volatile mining toward contracted digital infrastructure and support a little over 2x equity value by 2031.
|
| 56 |
AMPX
|
aerospace
defense
energy
hardware
transportation
|
Amprius Technologies, Inc.
|
2.1x
|
0.50
|
Amprius has a real silicon-anode edge in weight-sensitive batteries, and if it turns current drone, defense and mobility wins into repeat partner-manufactured volume while moving some value capture into compliance-ready modules and support, revenue can scale non-linearly even though the stock's hardware multiple should compress from today's premium level.
|
| 57 |
ALAB
|
ai
hardware
networking
semiconductors
software
|
Astera Labs, Inc.
|
2.1x
|
0.73
|
Astera is a leveraged toll collector on AI rack complexity: if Scorpio becomes repeatable production content across multiple hyperscaler and OEM platforms, the company can expand from retimers into switches, custom connectivity and a higher-value control layer, driving several-fold revenue growth by 2031; the catch is that today’s premium valuation likely turns that into a strong double, not a moonshot.
|
| 58 |
TWST
|
ai
automation
biotech
healthcare
|
Twist Bioscience Corporation
|
2.1x
|
0.58
|
Twist can turn AI-driven growth in biological design into a larger and more profitable synthetic DNA manufacturing franchise, but the real upside comes only if it converts scale, workflow embedding, and compliance trust into pricing power rather than just higher shipped volume.
|
| 59 |
AMKR
|
ai
automotive
communications
hardware
semiconductors
|
Amkor Technology, Inc.
|
2.1x
|
0.62
|
Amkor is a real AI-physical-infrastructure beneficiary: if it converts advanced packaging from a cyclical back-end service into earlier design-in, higher-value, customer-backed capacity, Arizona and mix shift can lift revenue and margins enough to support a durable rerating over five years.
|
| 60 |
META
|
advertising
ai
communications
hardware
media
|
Meta Platforms, Inc.
|
2.1x
|
0.78
|
Meta is a rare mega-cap where AI already improves the core cash engine: better ranking, targeting and measurement lift ad ROI now, while WhatsApp business agents, outcome-priced commerce ads and trust layers create additive capture. The stock is too large and capex-heavy for hypergrowth, but a durable 2x market-cap path by 2031 is realistic if monetization keeps outrunning compute and regulatory costs.
|
| 61 |
ASTS
|
communications
defense
hardware
networking
space
|
AST SpaceMobile, Inc.
|
2.1x
|
0.60
|
AST owns a scarce regulatory-and-physical control point in direct-to-device connectivity, so if it clears the 2026-2027 launch and activation sequence it can grow from milestone revenue into a global carrier reliability layer; the opportunity is real, but today’s valuation already assumes meaningful success.
|
| 62 |
CRWV
|
ai
cloud
enterprise
networking
software
|
CoreWeave, Inc.
|
2.1x
|
0.78
|
CoreWeave can still compound meaningfully because it controls one of the few scaled, financed paths from AI demand to powered GPU capacity, and recent inference and workflow products give it a credible way to monetize more per watt before raw compute scarcity normalizes.
|
| 63 |
DDOG
|
ai
cloud
cybersecurity
enterprise
software
|
Datadog, Inc.
|
2.1x
|
0.60
|
Datadog should remain a premium compounder because AI makes software estates more complex, failure-prone, and security-sensitive; the real upside is moving from metering telemetry to governing trusted automated operations inside an already deep enterprise footprint.
|
| 64 |
CRNC
|
ai
automotive
cloud
enterprise
software
|
Cerence Inc.
|
2.1x
|
0.60
|
Cerence is a small-cap automotive AI control point: if xUI converts existing OEM embedment into higher per-vehicle and recurring software revenue while free cash flow reduces debt, the stock can rerate from a noisy licensing story into a steadier embedded AI asset.
|
| 65 |
CRM
|
ai
automation
cloud
enterprise
software
|
Salesforce, Inc.
|
2.0x
|
0.60
|
Salesforce can roughly double enterprise value by May 2031 if it turns its huge CRM and service installed base into a richer mix of AI, data, integration, and governed workflow revenue; the upside does not need a euphoric rerating, but it does require paid production usage to outgrow seat pressure and weakness in older clouds.
|
| 66 |
CRDO
|
ai
cloud
hardware
networking
semiconductors
|
Credo Technology Group Holding Ltd
|
2.0x
|
0.74
|
Credo already owns a real AI interconnect bottleneck in low-power, high-reliability links; if it turns AEC leadership into broader optics, retimers and photonics content on the same hyperscaler programs, revenue can more than triple by 2031 even as the valuation multiple compresses from today’s peak.
|
| 67 |
NTRA
|
ai
biotech
healthcare
software
|
Natera, Inc.
|
2.0x
|
0.65
|
Natera can keep compounding as Signatera expands toward standard-of-care MRD monitoring and as women’s health, organ health, and workflow/data adjacencies deepen scale economics, but from a rich starting valuation the next five years depend more on turning evidence into reimbursed revenue and margins than on another major rerating.
|
| 68 |
CLS
|
ai
cloud
communications
hardware
networking
|
Celestica Inc.
|
2.0x
|
0.62
|
Celestica is a scarce, qualified builder of AI networking and rack-scale infrastructure; if its 2026-2027 capacity build converts into stickier platform, integration and lifecycle revenue, it can roughly double equity value by 2031 without needing a software-style multiple.
|
| 69 |
LSCC
|
ai
communications
cybersecurity
hardware
semiconductors
|
Lattice Semiconductor Corporation
|
2.0x
|
0.60
|
Lattice can compound by selling more trusted control, security, and manageability content around AI servers and intelligent edge devices; if AMI closes, it moves from a niche component supplier toward a broader rack and device management stack while keeping hardware-rooted stickiness.
|
| 70 |
SYM
|
ai
automation
enterprise
robotics
software
|
Symbotic Inc.
|
2.0x
|
0.65
|
Symbotic can still roughly double value by 2031 if it converts its backlog into a much larger installed base and raises recurring revenue per live site, but upside now depends more on deployment throughput, diversification, and trusted operating economics than on warehouse-robotics enthusiasm alone.
|
| 71 |
FN
|
automation
communications
hardware
networking
semiconductors
|
Fabrinet
|
2.0x
|
0.58
|
Fabrinet is a scarce, qualification-heavy manufacturing choke point for AI-era optical links; if it converts datacenter optics demand into loaded Thailand capacity and adds small trust and supply-assurance layers, revenue can roughly double by 2031, but value capture should still resemble a premium industrial rather than a software monopoly.
|
| 72 |
MSFT
|
ai
cloud
cybersecurity
enterprise
software
|
Microsoft Corporation
|
2.0x
|
0.84
|
Microsoft is one of the few firms that can monetize cheaper cognition at infrastructure, trust, and workflow layers at the same time; if capacity expands and Copilot shifts from seat attach to usage and governance revenue, a roughly 2x equity outcome by 2031 is plausible without multiple expansion.
|
| 73 |
SITM
|
ai
communications
hardware
networking
semiconductors
|
SiTime Corporation
|
2.0x
|
0.60
|
SiTime is a scarce precision-timing pure play that should benefit as AI inference, optical networking, and reliability-critical electronics require more timing content; if the Renesas timing deal closes and integration works, SiTime can grow from a premium socket vendor into a broader clocking franchise, though today’s valuation means shareholder upside depends on sustaining premium mix and avoiding commoditization.
|
| 74 |
TSM
|
ai
hardware
semiconductors
|
Taiwan Semiconductor Manufacturing Company Limited
|
2.0x
|
0.90
|
TSMC is the AI economy’s physical toll booth: if it keeps converting scarce leading-edge wafer and advanced-packaging capacity into shipped volume while avoiding geopolitical disruption, revenue can roughly double by 2031 and equity value can still compound from an already large base.
|
| 75 |
ORCL
|
ai
automation
cloud
enterprise
software
|
Oracle Corporation
|
2.0x
|
0.72
|
Oracle can still roughly double enterprise value by 2031 if it converts scarce powered OCI capacity into live cloud revenue, uses database and application lock-in to pull through multicloud and governed AI workloads, and captures more machine-driven usage than seat-based software deflation gives back.
|
| 76 |
WULF
|
ai
cloud
crypto
energy
|
TeraWulf Inc.
|
2.0x
|
0.68
|
TeraWulf can turn scarce power-backed campuses into a much larger base of contracted AI infrastructure revenue, but the stock now requires energized megawatts, funding discipline, and capital recycling—not just more site announcements—to create a clean double by 2031.
|
| 77 |
AMZN
|
advertising
ai
cloud
enterprise
transportation
|
Amazon.com, Inc.
|
2.0x
|
0.86
|
Amazon still looks like a strong compounding platform because AI makes scarce compute, trusted execution, and transaction rails more valuable, and Amazon already controls all three through AWS, embedded security/governance, and Prime fulfillment; if capex converts into usage, mix should shift upmarket enough to roughly double value by 2031.
|
| 78 |
HUT
|
ai
cloud
crypto
energy
enterprise
|
Hut 8 Corp.
|
2.0x
|
0.66
|
Hut 8 is best understood as a power-rights and AI campus development platform whose upside comes from converting scarce, financeable megawatts into long-duration contracted AI revenue faster than the market expects.
|
| 79 |
SMCI
|
ai
cloud
enterprise
hardware
networking
|
Super Micro Computer, Inc.
|
2.0x
|
0.58
|
Supermicro should remain a meaningful winner from AI infrastructure build-out because it owns fast design-to-deployment, rack integration, and liquid-cooling execution, but the equity upside is capped unless it converts that demand into cleaner margins, lower net debt, and restored trust; this is a good infrastructure compounding story, not a choke-point monopoly.
|
| 80 |
TSLA
|
ai
automotive
energy
robotics
transportation
|
Tesla, Inc.
|
2.0x
|
0.70
|
Tesla can still compound at a bull-case rate through 2031 if it converts its giant vehicle, charging and battery footprint into a higher-quality mix of energy, paid autonomy, fleet services and early robotics, with upside driven more by recurring control-point revenue than by car unit growth alone.
|
| 81 |
NET
|
ai
cloud
cybersecurity
networking
software
|
Cloudflare, Inc.
|
2.0x
|
0.68
|
Cloudflare can still compound from here if AI turns it into a default control point for traffic, APIs, Zero Trust, and agent execution, letting the company capture more high-value trust and governance spend per customer rather than merely more low-value edge traffic.
|
| 82 |
ANET
|
ai
cloud
hardware
networking
software
|
Arista Networks, Inc.
|
1.9x
|
0.74
|
Arista is a high-quality AI networking toll collector that can keep compounding if it turns constrained AI-fabric demand into a larger installed base, then monetizes that base with more software, support, and trust-layer services rather than staying a pure box-margin vendor.
|
| 83 |
COHR
|
automation
communications
hardware
networking
semiconductors
|
Coherent Corp.
|
1.9x
|
0.70
|
Coherent owns scarce qualified optical manufacturing at an AI bandwidth bottleneck; if it converts 6-inch indium phosphide scale, broader product coverage, and strategic customer commitments into shipped volume, revenue can more than double by 2031 even with some multiple compression.
|
| 84 |
RMBS
|
ai
cybersecurity
enterprise
hardware
semiconductors
|
Rambus Inc.
|
1.9x
|
0.63
|
Rambus owns valuable choke points in AI infrastructure—memory-interface chips, controller IP and silicon trust blocks—and can roughly triple revenue by 2031 if HBM, DDR5/SOCAMM2, client AI PC and security programs convert from launches into durable volume design wins; the main catch is that today’s valuation already prices in a meaningful share of that upside.
|
| 85 |
CDNS
|
ai
automation
enterprise
semiconductors
software
|
Cadence Design Systems, Inc.
|
1.9x
|
0.78
|
Cadence should remain a premium AI-era workflow tollbooth: as chips, packages, and AI factories get harder to design, trusted signoff, verification, emulation, IP, and system simulation become more valuable; the business can plausibly double revenue by 2031, but shareholders likely win through durable compounding rather than a huge rerating.
|
| 86 |
JBL
|
ai
automation
cloud
hardware
healthcare
|
Jabil Inc.
|
1.9x
|
0.54
|
Jabil is one of the cleaner ways to own AI hardware deployment without paying frontier-model multiples: if it converts scarce rack, power, cooling, and regulated manufacturing capacity into stickier system-level programs, revenue can compound while margins and valuation stay above classic contract-manufacturing norms.
|
| 87 |
PLTR
|
ai
cloud
defense
enterprise
software
|
Palantir Technologies Inc.
|
1.9x
|
0.76
|
Palantir can compound from a fast-growing AI software vendor into a governed action and coordination layer for defense and regulated enterprise workflows, but from today’s price most shareholder upside must come from sustained revenue compounding and monetizing trust/control surfaces rather than from more valuation expansion.
|
| 88 |
SNPS
|
ai
automation
enterprise
semiconductors
software
|
Synopsys, Inc.
|
1.9x
|
0.78
|
Synopsys should remain an AI-era engineering tollbooth: rising chip, packaging, verification, and system complexity sends more spend through its foundry-linked workflows, with upside coming from broader silicon-to-systems wallet share and trusted release layers rather than a speculative rerating.
|
| 89 |
AVGO
|
ai
cloud
networking
semiconductors
software
|
Broadcom Inc.
|
1.9x
|
0.80
|
Broadcom is one of the few mega-caps that can still outgrow its size because it sells scarce AI cluster content and owns a sticky private-cloud control layer, but shareholder upside is moderated by customer concentration and an already premium starting valuation.
|
| 90 |
BKSY
|
ai
defense
software
space
|
BlackSky Technology Inc.
|
1.9x
|
0.68
|
BlackSky can grow into a materially larger defense geospatial utility as Gen-3 capacity, Assured subscriptions, and sovereign programs expand, but from today’s premium valuation the stock needs recurring mix improvement, customer-funded capacity, and less dilution for operating progress to translate into strong shareholder returns.
|
| 91 |
MRVL
|
ai
cloud
hardware
networking
semiconductors
|
Marvell Technology, Inc.
|
1.8x
|
0.66
|
Marvell is a real AI-infrastructure beneficiary because custom silicon, optical links and switching content can compound faster than semiconductor averages, but the stock already discounts much of that success, so five-year returns depend more on sustained shipment conversion and mix than on further multiple expansion.
|
| 92 |
AMD
|
ai
cloud
enterprise
hardware
semiconductors
|
Advanced Micro Devices, Inc.
|
1.8x
|
0.74
|
AMD should keep taking share in AI infrastructure through EPYC server CPUs and Instinct-plus-Helios system ramps, but because the stock already prices in major success, the likely 5-year equity outcome is solid compounding rather than another explosive rerating unless ROCm and rack-scale execution make AMD a repeat default choice.
|
| 93 |
NVDA
|
ai
hardware
networking
semiconductors
software
|
NVIDIA Corporation
|
1.8x
|
0.95
|
NVIDIA should remain the default AI compute and interconnect stack through 2031, allowing revenue to roughly double as training broadens into inference, networking and software control layers; from a $5T base, that still supports a credible 2x equity outcome, but mostly through execution rather than another scarcity rerating.
|
| 94 |
DELL
|
ai
cloud
enterprise
hardware
networking
|
Dell Technologies Inc.
|
1.8x
|
0.60
|
Dell can turn AI infrastructure demand into a durable higher-earnings base through enterprise distribution, deployment, financing and storage attach; the realistic upside is a low-end double, not a chip-style supercycle, because supplier power and hardware economics cap value capture.
|
| 95 |
RGTI
|
cloud
hardware
quantum
semiconductors
|
Rigetti Computing, Inc.
|
1.8x
|
0.40
|
Rigetti owns a rare full-stack superconducting quantum asset base, so revenue can scale non-linearly if 108Q validation turns into repeatable system sales, reserved-capacity contracts, and trusted workflow products; but from a multi-billion-dollar starting valuation, shareholder upside depends on commercial proof arriving fast enough to outrun multiple compression.
|
| 96 |
PANW
|
ai
cloud
cybersecurity
enterprise
software
|
Palo Alto Networks, Inc.
|
1.8x
|
0.75
|
PANW should become a larger AI-era trust and enforcement layer as machine identities, agent traffic and automated response expand the attack surface, but from a $210B starting value the realistic win is premium compounding through deeper platform adoption and new verification-led monetization, not a dramatic rerating.
|
| 97 |
NTAP
|
ai
cloud
enterprise
hardware
software
|
NetApp, Inc.
|
1.8x
|
0.62
|
NetApp is not a frontier-AI winner, but its ONTAP control layer, hyperscaler-native distribution, and cyber-resilience attach can let it compound better than a typical storage vendor and earn a modest rerating as revenue mix shifts toward cloud, subscription, and policy-rich data operations.
|
| 98 |
CBRS
|
ai
cloud
enterprise
hardware
semiconductors
|
Cerebras Systems Inc.
|
1.8x
|
0.76
|
Cerebras is a real Last Economy beneficiary because ultra-fast inference is a scarce infrastructure input for agents, coding, and sovereign AI, but equity upside depends on converting marquee contracts into delivered, diversified, high-utilization capacity faster than valuation compresses.
|
| 99 |
AAOI
|
ai
communications
hardware
networking
semiconductors
|
Applied Optoelectronics, Inc.
|
1.8x
|
0.65
|
AAOI owns a real AI-era bottleneck in qualified laser and transceiver output, so revenue can compound hard if Texas and Taiwan ramps convert 800G and 1.6T demand into repeatable shipments; but because value capture is still mostly hardware margin with heavy capex and concentrated buyers, the likely 5-year stock outcome is strong rather than explosive.
|
| 100 |
VICR
|
ai
defense
energy
hardware
semiconductors
|
Vicor Corporation
|
1.8x
|
0.66
|
Vicor owns a real AI-era bottleneck in dense power delivery. If it converts backlog, licensing, and CHiP capacity expansion into repeatable multi-program shipments, revenue can compound hard through 2031; the catch is that today’s valuation already discounts a lot of success, so shareholder upside looks strong but not extreme.
|
| 101 |
VRT
|
automation
energy
hardware
networking
software
|
Vertiv Holdings Co
|
1.8x
|
0.76
|
Vertiv sells one of the scarcest inputs to the AI buildout: deployable power, cooling, rack, and service capacity. It can outgrow its market through converged systems, higher content per site, and deeper service attachment, but shareholder upside should come mainly from business compounding rather than another major valuation rerating.
|
| 102 |
MPWR
|
ai
automotive
communications
hardware
semiconductors
|
Monolithic Power Systems, Inc.
|
1.7x
|
0.69
|
MPWR is a high-quality pick-and-shovels beneficiary of denser AI, optical and automotive power architectures; if it keeps turning sticky sockets into higher-content modules and subsystem wins while scaling qualified supply, revenue can roughly triple by 2031, but the stock’s starting premium likely limits upside to solid rather than explosive.
|
| 103 |
ARM
|
ai
cloud
hardware
semiconductors
|
Arm Holdings plc
|
1.7x
|
0.82
|
Arm is a rare AI-era architecture tollbooth: if Armv9 mix, CSS, data-center royalties and selected silicon all scale, revenue can roughly triple by 2031; but the stock already capitalizes much of that strategic importance, so shareholder returns should lag business growth.
|
| 104 |
TLN
|
ai
energy
nuclear
|
Talen Energy Corporation
|
1.7x
|
0.60
|
Talen can still compound equity value by moving scarce PJM-connected nuclear and gas capacity from mostly merchant exposure toward longer-duration AI-load, reliability, and campus-style cash flows; the upside is meaningful because the assets already exist, but it remains capped by regulation, concentration at Susquehanna, and a stock that already reflects part of the scarcity story.
|
| 105 |
CRWD
|
ai
cloud
cybersecurity
enterprise
software
|
CrowdStrike Holdings, Inc.
|
1.7x
|
0.80
|
CrowdStrike should keep compounding as AI expands the attack surface and pushes enterprises toward fewer trusted security control planes; its telemetry, single-agent architecture, and Falcon Flex motion support strong revenue growth, but today’s valuation means shareholders likely get solid rather than explosive returns unless new AI-era products become major revenue pools.
|
| 106 |
MTSI
|
communications
defense
hardware
networking
semiconductors
|
MACOM Technology Solutions Holdings, Inc.
|
1.7x
|
0.70
|
MACOM should outgrow most analog semiconductor peers because AI build-outs need more optical/copper interconnect and trusted RF content, but stock upside depends on proving it can monetize qualification, supply assurance and subsystem value rather than just ship more discrete parts.
|
| 107 |
VST
|
energy
nuclear
|
Vistra Corp.
|
1.7x
|
0.70
|
Vistra is a scarce-megawatt quality-upgrade story: AI-era load growth makes its existing nuclear and dispatchable gas fleet more valuable, and longer contracts, Cogentrix scale, selective brownfield development, and buybacks can turn moderate revenue growth into stronger per-share equity compounding by 2031.
|
| 108 |
GOOG
|
advertising
ai
cloud
enterprise
media
|
Alphabet Inc.
|
1.7x
|
0.72
|
Alphabet should keep compounding because Search and YouTube still fund the compute build, Cloud is becoming a second engine, and AI can shift some value capture from clicks toward actions, trust, and infrastructure. The upside is meaningful, but sheer size, capex intensity, and regulatory remedies cap the odds of a dramatic rerating.
|
| 109 |
CEG
|
ai
energy
nuclear
|
Constellation Energy Corporation
|
1.7x
|
0.78
|
CEG is a scarce clean-and-flexible power landlord: if it turns nuclear licenses, gas flexibility, customer relationships and power-ready sites into repeatable reservation-plus-uptime contracts, it can compound more like an infrastructure toll road than a normal merchant generator through 2031.
|
| 110 |
ETN
|
aerospace
automation
energy
hardware
software
|
Eaton Corporation plc
|
1.6x
|
0.74
|
Eaton is a high-quality picks-and-shovels way to own AI-driven electrification: scarce switchgear, broad channel access, modular power systems and added thermal content should keep growth above industrial norms, but the next five years hinge on converting constrained capacity into profitable shipments and lifting mix after the Mobility separation.
|
| 111 |
LITE
|
cloud
communications
hardware
networking
semiconductors
|
Lumentum Holdings Inc.
|
1.6x
|
0.66
|
Lumentum is a real AI infrastructure bottleneck owner in qualified lasers and photonics, so revenue can still compound hard through 2031; but because the stock already discounts a large share of that scarcity, equity upside depends on turning temporary shortage into durable contracts, broader customer depth, and sustained mix-led margins.
|
| 112 |
BWXT
|
defense
energy
healthcare
nuclear
|
BWX Technologies, Inc.
|
1.6x
|
0.72
|
BWXT should keep compounding as a scarce owner of trusted nuclear throughput, naval qualification and fuel-cycle know-how; AI-era power demand helps, but the stock already embeds rarity, so 5-year upside likely comes from steady backlog conversion, commercial capacity expansion and mix improvement rather than a dramatic rerating.
|
| 113 |
PL
|
aerospace
ai
defense
software
space
|
Planet Labs PBC
|
1.6x
|
0.60
|
Planet owns a scarce daily Earth-data archive that gets more valuable as AI makes geospatial interpretation cheap, but over the next five years shareholder upside will depend less on relevance and more on turning sovereign backlog, Pelican capacity, and workflow control into revenue fast enough to outrun a very rich starting valuation.
|
| 114 |
STEM
|
ai
automation
energy
enterprise
software
|
Stem, Inc.
|
1.6x
|
0.50
|
Stem is a real operating-software business inside a distressed capital structure: if PowerTrack keeps shifting from monitoring into control, compliance, and verification, modest revenue growth plus lower perceived financing risk can still create attractive equity upside from a very small current market cap.
|
| 115 |
EQIX
|
ai
cloud
energy
enterprise
networking
|
Equinix, Inc.
|
1.5x
|
0.80
|
Equinix should remain an AI-era toll booth: cheaper cognition and more agentic traffic raise the value of scarce powered metros, private interconnection and trusted neutral adjacency, but shareholder upside is capped by power-constrained build cycles, heavy reinvestment and an already premium starting valuation.
|
| 116 |
ON
|
ai
automotive
energy
hardware
semiconductors
|
ON Semiconductor Corporation
|
1.5x
|
0.65
|
onsemi should grow faster than a normal cyclical analog peer because AI rack power, higher-voltage vehicles, and richer automotive electronics expand its content per system, but the stock outcome is capped by owned-fab cyclicality and the fact that much of its value still sits in a competitive component layer rather than a monopoly control point.
|
| 117 |
PWR
|
communications
energy
|
Quanta Services, Inc.
|
1.5x
|
0.60
|
Quanta is one of the few scaled contractors positioned to monetize the AI-era power buildout through scarce craft labor, engineering depth and schedule certainty; over five years it should outgrow most industrial peers, but shareholder upside likely comes from sustained execution and better mix rather than a major rerating.
|
| 118 |
ASML
|
ai
automation
hardware
semiconductors
|
ASML Holding N.V.
|
1.5x
|
0.90
|
ASML remains one of the clearest physical chokepoints in the AI buildout: more leading-edge logic and memory capacity drives more lithography intensity, the installed base adds recurring capture, and selective contract innovation could widen monetization, but the stock already prices exceptional quality so the likely outcome is premium compounding rather than nonlinear rerating.
|
| 119 |
MU
|
ai
enterprise
hardware
semiconductors
|
Micron Technology, Inc.
|
1.5x
|
0.78
|
Micron is a real AI-era bottleneck asset because it controls scarce memory fabs, advanced packaging and customer qualification slots, but from a trillion-dollar equity base the key question is no longer demand; it is whether Micron can turn HBM, server DRAM and data-center SSD strength into less-cyclical value capture before industry supply catches up.
|
| 120 |
RKLB
|
aerospace
defense
hardware
space
|
Rocket Lab Corporation
|
1.5x
|
0.68
|
Rocket Lab can become a much larger space-and-defense prime by 2031 as Neutron, defense backlog, and vertically integrated components expand revenue per customer, but the stock already prices in a large share of that future, so excellent execution likely creates only moderate equity upside.
|
| 121 |
NEE
|
automation
energy
nuclear
|
NextEra Energy, Inc.
|
1.5x
|
0.80
|
NextEra should keep compounding above utility peers because AI-driven power scarcity raises the value of its regulated grid access, generation fleet and build engine; the upside is durable rather than explosive because regulators, customers and capital providers share the economics.
|
| 122 |
HPE
|
cloud
enterprise
hardware
networking
software
|
Hewlett Packard Enterprise Company
|
1.4x
|
0.60
|
HPE is a quality-upgrade AI infrastructure story: if Juniper makes networking a larger profit engine and GreenLake plus financing deepen recurring attach, HPE can compound faster than a normal hardware vendor even without a dramatic software-style rerating.
|